Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/47842
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Başaran M. | - |
dc.contributor.author | Öztanir M.N. | - |
dc.contributor.author | Çıftçı O. | - |
dc.contributor.author | Başak Türkmen N. | - |
dc.contributor.author | Akyuva Y. | - |
dc.contributor.author | Önder A. | - |
dc.date.accessioned | 2023-01-09T21:30:21Z | - |
dc.date.available | 2023-01-09T21:30:21Z | - |
dc.date.issued | 2022 | - |
dc.identifier.issn | 1309-4483 | - |
dc.identifier.uri | https://doi.org/10.52142/omujecm.39.2.28 | - |
dc.identifier.uri | https://hdl.handle.net/11499/47842 | - |
dc.description.abstract | The Neuroprotective effect of carvacrol, which has anti-inflammatory and antioxidant effects, on infarcted cerebral tissue is present in literature, but this contribution was not sufficiently clarified in terms of biochemistry. It is aimed to investigate the effect of orally administered carvacrol on plasma and intraparenchymal levels of TBARS, GSH, SOD, CAT, GSH-Px, IL-1?, IL-4, and TNF-? after the formation of global ischemia in cerebral tissue. Four groups were formed, each containing ten Wistar albino rats. After anesthesia and analgesia, bilateral carotid communis arteries of rats in the first two groups were clamped for 15 minutes with aneurysm clips. Oral 50 mg/kg/day carvacrol was administered for 15 days to the first group (I/R+CRV) of these two groups in which cerebral ischemia-reperfusion (I/R) was established. On the other hand, %0,01 carboxymethylcellulose (CMC), which is a solvent of carvacrol, at a same volume of first group was administered orally for the same duration to the other group in which also I/R was established (I/R+CMC). In the other two groups in which ischemia was not induced, only carotid artery dissections were made and sutured again. In these two groups, 50 mg/kg/day of carvacrol was administered to the first group (CRV). The Same dose of CMC was administered to the second group (control group). After all these treatments, plasma was collected, and brain tissue was dissected from all groups at the end of the 15th day. Carvacrol can be included in the possible treatment regimen of cerebral stroke with the help of other studies that can be supported on this topic. © 2022 Ondokuz Mayis Universitesi. All rights reserved. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Ondokuz Mayis Universitesi | en_US |
dc.relation.ispartof | Journal of Experimental and Clinical Medicine (Turkey) | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | carvacrol | en_US |
dc.subject | CAT | en_US |
dc.subject | CMC | en_US |
dc.subject | GSH | en_US |
dc.subject | GSH-Px | en_US |
dc.subject | IL-1? | en_US |
dc.subject | IL-4 | en_US |
dc.subject | ischemia reperfusion | en_US |
dc.subject | SOD | en_US |
dc.subject | TBARS | en_US |
dc.subject | TNF-? | en_US |
dc.subject | carboxymethylcellulose | en_US |
dc.subject | carvacrol | en_US |
dc.subject | catalase | en_US |
dc.subject | glutathione | en_US |
dc.subject | interleukin 1beta | en_US |
dc.subject | interleukin 4 | en_US |
dc.subject | superoxide dismutase | en_US |
dc.subject | thiobarbituric acid reactive substance | en_US |
dc.subject | tumor necrosis factor | en_US |
dc.subject | animal experiment | en_US |
dc.subject | animal model | en_US |
dc.subject | animal tissue | en_US |
dc.subject | antiinflammatory activity | en_US |
dc.subject | antioxidant activity | en_US |
dc.subject | Article | en_US |
dc.subject | carotid artery injury | en_US |
dc.subject | cerebral ischemia reperfusion injury | en_US |
dc.subject | controlled study | en_US |
dc.subject | drug effect | en_US |
dc.subject | experimental cerebral ischemia | en_US |
dc.subject | male | en_US |
dc.subject | neuroprotection | en_US |
dc.subject | nonhuman | en_US |
dc.subject | rat | en_US |
dc.subject | rat model | en_US |
dc.title | Neuroprotective effect of carvacrol in an experimental cerebral ischemia and reperfusion rat model | en_US |
dc.type | Article | en_US |
dc.identifier.volume | 39 | en_US |
dc.identifier.issue | 2 | en_US |
dc.identifier.startpage | 454 | en_US |
dc.identifier.endpage | 458 | en_US |
dc.identifier.doi | 10.52142/omujecm.39.2.28 | - |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.authorscopusid | 57967795300 | - |
dc.authorscopusid | 56033953500 | - |
dc.authorscopusid | 27867577100 | - |
dc.authorscopusid | 57208011277 | - |
dc.authorscopusid | 56033997900 | - |
dc.authorscopusid | 6603710997 | - |
dc.identifier.scopus | 2-s2.0-85142061949 | en_US |
dc.identifier.scopusquality | Q4 | - |
item.languageiso639-1 | en | - |
item.grantfulltext | open | - |
item.fulltext | With Fulltext | - |
item.cerifentitytype | Publications | - |
item.openairetype | Article | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
Appears in Collections: | Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu |
Files in This Item:
File | Size | Format | |
---|---|---|---|
Neuroprotective effect of carvacrol.pdf | 619.11 kB | Adobe PDF | View/Open |
CORE Recommender
SCOPUSTM
Citations
1
checked on Nov 23, 2024
Page view(s)
42
checked on Aug 24, 2024
Download(s)
10
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.